The sporadic nature of shedding cells in blood: Multiple RNA diagnostic testing and prognostication of cancer progression

Clinical Chemistry

Volumn 49, Issue 9, 2003, Pages 1429-1431

  Wong, Ivy H N ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

MONOPHENOL MONOOXYGENASE; PROSTATE SPECIFIC ANTIGEN;

CANCER; CANCER GROWTH; CANCER RECURRENCE; CANCER SURVIVAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; EARLY DIAGNOSIS; EDITORIAL; HUMAN; MELANOMA; MELANOMA CELL; PROGNOSIS; PROSTATE CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

DISEASE PROGRESSION; HUMANS; MELANOMA; MONOPHENOL MONOOXYGENASE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0041441139     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/49.9.1429     Document Type: Editorial

References (19)

1. Smith B, Selby P, Southgate J, Pittman K, Bradley C, Blair GE. Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet 1991;338:1227-9.
2. Wong IHN. Transcriptional profiling of circulating tumor cells: quantification and cancer progression [Review]. Oncol Rep 2003;10:229-35.
3. Blaheta HJ, Ellwanger U, Schittek B, Sotlar K, MacZey E, Breuninger H, et al. Examination of regional lymph nodes by sentinel node biopsy and molecular analysis provides new staging facilities in primary cutaneous melanoma. J Invest Dermatol 2000;114:637-42.
4. Blaheta HJ, Paul T, Sotlar K, Maczey E, Schittek B, Paul A, et al. Detection of melanoma cells in sentinel lymph nodes, bone marrow and peripheral blood by a reverse transcription-polymerase chain reaction assay in patients with primary cutaneous melanoma: association with Breslow's tumour thickness. Br J Dermatol 2001;145:195-202.
5. Shivers SC, Wang X, Li W, Joseph E, Messina J, Glass LF, et al. Molecular staging of malignant melanoma: correlation with clinical outcome. JAMA 1998;280:1410-5.
6. Proebstle TM, Jiang W, Hogel J, Keilholz U, Weber L, Voit C. Correlation of positive RT-PCR for tyrosinase in peripheral blood of malignant melanoma patients with clinical stage, survival and other risk factors. Br J Cancer 2000;82:118-23.
7. Gogas H, Kefala G, Bafaloukos D, Frangia K, Polyzos A, Pectasides D, et al. Prognostic significance of the sequential detection of circulating melanoma cells by RT-PCR in high-risk melanoma patients receiving adjuvant interferon. Br J Cancer 2002;87:181-6.
8. Szenajch J, Jasinski B, Synowiec A, Kulik J, Chomicka MG, Struzyna J, et al. Prognostic value of multiple reverse transcription-PCR tyrosinase testing for circulating neoplastic cells in malignant melanoma. Clin Chem 2003;49:1450-7.
9. Wong IHN, Leung T, Ho S, Lau WY, Chan M, Johnson PJ. Semiquantification of circulating hepatocellular carcinoma cells by reverse transcriptase polymerase chain reaction. Br J Cancer 1997;76:628-33.
10. Wong IHN, Lau WY, Leung T, Yeo W, Johnson PJ. Hematogenous dissemination of hepatocytes and tumor cells after surgical resection of hepatocellular carcinoma: a quantitative analysis. Clin Cancer Res 1999;5:4021-7.
11. Wong IHN, Yeo W, Leung T, Lau WY, Johnson PJ. Circulating tumor cell mRNAs in peripheral blood from hepatocellular carcinoma patients under radiotherapy, surgical resection or chemotherapy: a quantitative evaluation. Cancer Lett 2001;167:183-91.
12. Wong IHN, Chan AT, Johnson PJ. Quantitative analysis of circulating tumor cells in peripheral blood of osteosarcoma patients using osteoblast-specific messenger RNA markers: a pilot study. Clin Cancer Res 2000;6:2183-8.
13. Wong IHN, Yeo W, Chan AT, Johnson PJ. Quantitative correlation of cytokeratin 19 mRNA level in peripheral blood with disease stage and metastasis in breast cancer patients: potential prognostic implications. Int J Oncol 2001;18:633-8.
14. Gelmini S, Tricarico C, Vona G, Livi L, Melina AD, Serni S, et al. Real-time quantitative reverse transcriptase-poymerase chain reaction (RT-PCR) for the measurement of prostate-specific antigen mRNA in the peripheral blood of patients with prostate carcinoma using the TaqMan detection system. Clin Chem Lab Med 2001;39:385-91.
15. Wood DR, Banerjee M. Presence of circulating prostate cells in the bone marrow of patients undergoing radical prostatectomy is predictive of disease-free survival. J Clin Oncol 1997;15:3451-7.
16. Melchior SW, Corey E, Ellis WJ, Ross AA, Layton TJ, Oswin MM, et al. Early tumor cell dissemination in patients with clinically localized carcinoma of the prostate. Clin Cancer Res 1997;3:249-56.
17. Schamhart D, Swinnen J, Kurth K-H, Westerhof A, Kusters R, Botchers H, et al. Numeric definition of the clinical performance of the nested reverse transcription-PCR for detection of hematogenous epithelial cells and correction for specific mRNA of non-target cell origin as evaluated for prostate cancer cells. Clin Chem 2003;49:1458-66.
18. Gala JL, Heusterspreute M, Loric S, Hanon F, Tombal B, Van Cangh P, et al. Expression of prostate-specific antigen and prostate-specific membrane antigen transcripts in blood cells: implications for the detection of hematogenous prostate cells and standardization. Clin Chem 1998;44:472-81.
19. Thomas J, Gupta M, Grasso Y, Reddy CA, Heston WD, Zippe C, et al. Preoperative combined nested reverse transcriptase polymerase chain reaction for prostate-specific antigen and prostate-specific membrane antigen does not correlate with pathologic stage or biochemical failure in patients with localized prostate cancer undergoing radical prostatectomy. J Clin Oncol 2002;20:3213-8.